Skip to main content
OpenTrials

Clinical trial condition

Hepatocellular Carcinoma

Explore clinical trials studying Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

1,013 public trials 264 recruiting studies
Refine in advanced search Browse all conditions

Hepatocellular Carcinoma trial results

Active, Not Recruiting

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

NCT06679985

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • University of Arizona - Cancer Center Tucson, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • City of Hope Duarte, California, United States
View all 44 locations
View Trial Details
Active, Not Recruiting

A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma

NCT03778957

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Research Site Costa Mesa, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Orange, California, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 166 locations
View Trial Details
Active, Not Recruiting

Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC

NCT05301842

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Mobile, Alabama, United States
  • Research Site Yuma, Arizona, United States
  • Research Site Glendale, California, United States
View all 171 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis

NCT06096779

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of Southern California-Keck School of Medicine -1975 Zonal Ave Los Angeles, California, United States
  • University of Southern California Newport Beach, California, United States
View all 59 locations
View Trial Details
Active, Not Recruiting

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

NCT05775159

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
  • Research Site Kansas City, Kansas, United States
View all 46 locations
View Trial Details

Related conditions